Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate

NCT: NCT06642116 · COMPLETED

NCT IDNCT06642116
StatusCOMPLETED
Start Date2025-02-10
Completion2025-08-25
SponsorPolyganics BV (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to investigate the safety and performance of OCEAN® as an adjunct in wound healing after nasal/sinus surgery by using OCEAN® in patients undergoing nasal/sinus surgery.

Frequently Asked Questions

What is Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate?

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate is a clinical trial registered under NCT06642116. Current status: COMPLETED.

What is the status of NCT06642116?

The current status of NCT06642116 (Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate) is: COMPLETED.

When did Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate start?

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate started on 2025-02-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.